Vanda Pharmaceuticals Inc.

8-K Shareholder vote results Jun 5, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 6, 2026 8-K Director or officer change Apr 22, 2026 8-K Director or officer change Apr 2, 2026 8-K Regulation FD disclosure Mar 10, 2026 8-K Other events Feb 23, 2026 8-K Director or officer change Feb 19, 2026 10-K Fiscal year ended 2025-12-31 Feb 12, 2026 8-K Results of operations (earnings release) Feb 11, 2026 8-K Other events Jan 8, 2026 8-K Other events Dec 31, 2025 8-K Other events Dec 4, 2025 8-K Other events Nov 28, 2025 10-Q Quarter ended 2025-09-30 Oct 30, 2025 8-K Results of operations (earnings release) Oct 29, 2025 8-K Other events Oct 1, 2025 10-Q Quarter ended 2025-06-30 Jul 31, 2025 8-K Results of operations (earnings release) Jul 31, 2025 8-K Shareholder vote results Jun 5, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 7, 2025 8-K Regulation FD disclosure Mar 17, 2025 8-K Director or officer change Feb 20, 2025 10-K Fiscal year ended 2024-12-31 Feb 14, 2025 8-K Results of operations (earnings release) Feb 13, 2025 8-K Regulation FD disclosure Jan 27, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 6, 2024 8-K Other events Oct 15, 2024 8-K Amended charter or bylaws Oct 3, 2024 8-K Other events Sep 19, 2024 8-K Entered a material agreement; Modified rights of security holders Aug 8, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024 8-K Results of operations (earnings release) Jul 31, 2024 8-K Other events Jun 20, 2024 8-K Other events Jun 13, 2024 8-K Regulation FD disclosure Jun 6, 2024 8-K Other events May 24, 2024 8-K/A Shareholder vote results May 24, 2024